Thus, to circumvent the problem, impacting pathways controlled by Myc such as the mevalonate pathway by decrease in phosphomevalonate kinase could be considered as one of the strategies to inhibit its role in cancer-cell proliferation. The gene discussed is MYC; the disease is cancer.